Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 0.88 as of 2026-10-06T15:41:06.939Z.
Calculation as of: 2026-10-06T15:41:06.939Z.
Quote observation: 2026-10-06T15:37:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dd458a7b7530169a13c79e175a6610edc18df904cb2af71895118b3708428af2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.88
SECTOR MEDIAN · HEALTHCARE
2.38
median of 610 covered companies
CURRENT VS SECTOR MEDIAN
-63.10%
vs the sector median at left
Market Cap
$60.53M
PB Ratio
2.25
TTM Avg
2.67
3Y Avg
1.93
5Y Avg
2.46
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.98M | 0.88 | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | N/A | 6.85 | 6.82 | 6.82 |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | 4.62 | 4.53 | 4.53 | 9.84 |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | N/A | 7.09 | 5.05 | 5.05 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | N/A | 462.09 | 158.47 | 96.29 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.53M | 2.25 | 2.67 | 1.93 | 2.46 |
| PDS Biotechnology Corporation (PDSB)vs › | $60.49M | N/A | 5.95 | 4.54 | 4.16 |
| Spectral AI, Inc. (MDAI)vs › | $55.08M | N/A | 27.03 | 27.03 | 27.03 |
| Adicet Bio, Inc. (ACET)vs › | $61.21M | 0.51 | 0.53 | 0.47 | 0.88 |
| Aldeyra The (ALDX)vs › | $54.53M | 1.44 | 4.03 | 3.30 | 2.88 |
P/B Ratio
0.88
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
